Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 90
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Int J Mol Sci ; 22(21)2021 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-34769028

RESUMEN

Ribosome-inactivating proteins (RIPs) hydrolyze the N-glycosidic bond and depurinate a specific adenine residue (A-4324 in rat 28S ribosomal RNA, rRNA) in the conserved α-sarcin/ricin loop (α-SRL) of rRNA. In this study, we have purified and characterized lyophyllin, an unconventional RIP from Lyophyllum shimeji, an edible mushroom. The protein resembles peptidase M35 domain of peptidyl-Lys metalloendopeptidases. Nevertheless, protein either from the mushroom or in recombinant form possessed N-glycosidase and protein synthesis inhibitory activities. A homology model of lyophyllin was constructed. It was found that the zinc binding pocket of this protein resembles the catalytic cleft of a classical RIP, with key amino acids that interact with the adenine substrate in the appropriate positions. Mutational studies showed that E122 may play a role in stabilizing the positively charged oxocarbenium ion and H121 for protonating N-3 of adenine. The tyrosine residues Y137 and Y104 may be used for stacking the target adenine ring. This work first shows a protein in the peptidase M35 superfamily based on conserved domain search possessing N-glycosidase activity.


Asunto(s)
Agaricales/metabolismo , Péptido Hidrolasas/metabolismo , Proteínas Inactivadoras de Ribosomas/metabolismo , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Endorribonucleasas/metabolismo , Proteínas Fúngicas/metabolismo , Células HeLa , Células Hep G2 , Humanos , Unión Proteica/fisiología , ARN Ribosómico 28S/metabolismo , Ratas , Ricina/metabolismo
2.
Toxins (Basel) ; 10(8)2018 08 08.
Artículo en Inglés | MEDLINE | ID: mdl-30096764

RESUMEN

Bougainvillea (Bougainvillea spectabilis Willd.) is a plant widely used in folk medicine and many extracts from different tissues of this plant have been employed against several pathologies. The observation that leaf extracts of Bougainvillea possess antiviral properties led to the purification and characterization of a protein, named bouganin, which exhibits typical characteristics of type 1 ribosome-inactivating proteins (RIPs). Beyond that, bouganin has some peculiarities, such as a higher activity on DNA with respect to ribosomal RNA, low systemic toxicity, and immunological properties quite different than other RIPs. The sequencing of bouganin and the knowledge of its three-dimensional structure allowed to obtain a not immunogenic mutant of bouganin. These features make bouganin a very attractive tool as a component of immunotoxins (ITs), chimeric proteins obtained by linking a toxin to a carrier molecule. Bouganin-containing ITs showed very promising results in the experimental treatment of both hematological and solid tumors, and one bouganin-containing IT has entered Phase I clinical trial. In this review, we summarize the milestones of the research on bouganin such as bouganin chemico-physical characteristics, the structural properties and de-immunization studies. In addition, the in vitro and in vivo results obtained with bouganin-containing ITs are summarized.


Asunto(s)
Inmunotoxinas/farmacología , Proteínas Inactivadoras de Ribosomas/farmacología , Animales , Antígenos/química , Antígenos/farmacología , Antivirales/química , Antivirales/farmacología , Humanos , Conformación Proteica , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacología , Proteínas Inactivadoras de Ribosomas/química
3.
Pak J Pharm Sci ; 31(2): 379-384, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29618424

RESUMEN

Ribosome Inactivating Proteins (RIPs) isolated from Mirabilis jalapa L. (MJ protein) leaves showed high cytotoxic effect on malignant. Chitosan nanoparticles have frequently been used in protein delivery applications. The aim of this study was to develop targeted drug delivery system of RIP MJ for breast cancer therapy with chitosan nanoparticles conjugated antiEpCAM antibody. RIP MJ nanoparticles were prepared using low viscous chitosan and pectin using polyelectrolit complex method, followed by conjugation process with antiEpCAM antibody. Characterization of this formula was then carried out for its entrapment efficiency, particles size, zeta potential, morphology using transmission electron microscope (TEM) and cytotoxic assay against T47D and Vero cell line. The optimal concentration of MJ protein; low viscous chitosan; pectin for preparing AntiEpCAM conjugated of RIP MJ nanoparticles was 0.1%; 0.01%;1% (m/v) respectively and showed satisfactory formula with the average particle size of 376.8±105.2nm, polydispersity index (PI) 0.401, zeta potential 43,71 mV, high entrapment efficiency 98,97±0,12%. Transmission electron microscope (TEM) imaging showed a spherical and homogenous structure for nanoparticles. The in vitro cytotoxicity analysis showed that RIP MJ nanoparticle had more cytotoxic effect compared to unformulated RIP against T47D cell-lines. AntiEpCAM conjugated RIP MJ nanoparticles however, increased cytotoxic effect of RIPs on Vero cell-lines not for T47D cell-lines. Chitosan-Pectin nanoparticles suitable for delivering protein to target cancer cells.


Asunto(s)
Antineoplásicos Fitogénicos/química , Neoplasias de la Mama/tratamiento farmacológico , Mirabilis/química , Nanopartículas/química , Proteínas Inactivadoras de Ribosomas/farmacología , Anticuerpos/química , Antineoplásicos Fitogénicos/farmacología , Neoplasias de la Mama/patología , Línea Celular Tumoral , Quitosano/química , Sistemas de Liberación de Medicamentos/métodos , Molécula de Adhesión Celular Epitelial/inmunología , Femenino , Humanos , Microscopía Electrónica de Transmisión , Nanopartículas/administración & dosificación , Pectinas/química , Proteínas Inactivadoras de Ribosomas/química , Proteínas Inactivadoras de Ribosomas/aislamiento & purificación
4.
Biotechnol Lett ; 39(7): 1049-1058, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28365881

RESUMEN

OBJECTIVES: To engineer broad spectrum resistance in potato using different expression strategies. RESULTS: The previously identified Ribosome-Inactivating Protein from Phytolacca heterotepala was expressed in potato under a constitutive or a wound-inducible promoter. Leaves and tubers of the plants constitutively expressing the transgene were resistant to Botrytis cinerea and Rhizoctonia solani, respectively. The wound-inducible promoter was useful in driving the expression upon wounding and fungal damage, and conferred resistance to B. cinerea. The observed differences between the expression strategies are discussed considering the benefits and features offered by the two systems. CONCLUSIONS: Evidence is provided of the possible impact of promoter sequences to engineer BSR in plants, highlighting that the selection of a suitable expression strategy has to balance specific needs and target species.


Asunto(s)
Resistencia a la Enfermedad , Expresión Génica , Organismos Modificados Genéticamente/inmunología , Enfermedades de las Plantas/prevención & control , Proteínas Recombinantes/metabolismo , Proteínas Inactivadoras de Ribosomas/metabolismo , Solanum tuberosum/inmunología , Botrytis/inmunología , Botrytis/patogenicidad , Regulación de la Expresión Génica de las Plantas , Organismos Modificados Genéticamente/genética , Phytolacca/enzimología , Phytolacca/genética , Enfermedades de las Plantas/microbiología , Proteínas Recombinantes/genética , Rhizoctonia/inmunología , Rhizoctonia/patogenicidad , Proteínas Inactivadoras de Ribosomas/genética , Solanum tuberosum/genética
5.
DNA Res ; 24(1): 51-58, 2017 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-28028039

RESUMEN

Bitter gourd (Momordica charantia) is an important vegetable and medicinal plant in tropical and subtropical regions globally. In this study, the draft genome sequence of a monoecious bitter gourd inbred line, OHB3-1, was analyzed. Through Illumina sequencing and de novo assembly, scaffolds of 285.5 Mb in length were generated, corresponding to ∼84% of the estimated genome size of bitter gourd (339 Mb). In this draft genome sequence, 45,859 protein-coding gene loci were identified, and transposable elements accounted for 15.3% of the whole genome. According to synteny mapping and phylogenetic analysis of conserved genes, bitter gourd was more related to watermelon (Citrullus lanatus) than to cucumber (Cucumis sativus) or melon (C. melo). Using RAD-seq analysis, 1507 marker loci were genotyped in an F2 progeny of two bitter gourd lines, resulting in an improved linkage map, comprising 11 linkage groups. By anchoring RAD tag markers, 255 scaffolds were assigned to the linkage map. Comparative analysis of genome sequences and predicted genes determined that putative trypsin-inhibitor and ribosome-inactivating genes were distinctive in the bitter gourd genome. These genes could characterize the bitter gourd as a medicinal plant.


Asunto(s)
Genoma de Planta , Momordica charantia/genética , Plantas Medicinales/genética , Clima Tropical , Elementos Transponibles de ADN , Filogenia , Proteínas Inactivadoras de Ribosomas/genética , Inhibidores de Tripsina/metabolismo
6.
Molecules ; 21(11)2016 Nov 18.
Artículo en Inglés | MEDLINE | ID: mdl-27869738

RESUMEN

Ribosome-inactivating proteins (RIPs) are enzymes that deadenylate nucleic acids and are broadly distributed in the plant kingdom. Many plants that contain RIPs are listed in the pharmacopoeias of folk medicine all over the world, mostly because of their toxicity. This review analyses the position occupied in traditional medicine by plants from which RIPs have been isolated. The overview starts from the antique age of the Mediterranean area with ancient Egypt, followed by the Greek and Roman classic period. Then, the ancient oriental civilizations of China and India are evaluated. More recently, Unani medicine and European folk medicine are examined. Finally, the African and American folk medicines are taken into consideration. In conclusion, a list of RIP-expressing plants, which have been used in folk medicine, is provided with the geographical distribution and the prescriptions that are recommended by traditional healers. Some final considerations are provided on the present utilization of such herbal treatments, both in developing and developed countries, often in the absence of scientific validation. The most promising prospect for the medicinal use of RIP-expressing plants is the conjugation of purified RIPs to antibodies that recognise tumour antigens for cancer therapy.


Asunto(s)
Medicina Tradicional China , Proteínas de Plantas/uso terapéutico , Plantas Medicinales/química , Proteínas Inactivadoras de Ribosomas/uso terapéutico , Animales , Humanos , Farmacopeas como Asunto , Fitoterapia , Proteínas de Plantas/metabolismo , Plantas Medicinales/metabolismo , Proteínas Inactivadoras de Ribosomas/metabolismo
7.
Plant Foods Hum Nutr ; 71(3): 265-71, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27319013

RESUMEN

Ribosome inactivating proteins (RIPs) have received considerable attention in biomedical research because of their unique activities towards tumor and virus-infected cells. We extracted balsamin, a type-I RIP, from Momordica balsamina. In the present study, a detailed investigation on DNase activity, antioxidant capacity and antibacterial activity was conducted using purified balsamin. DNase-like activity of balsamin towards plasmid DNA was pH, incubation time and temperature dependent. Moreover, the presence of Mg(2+) (10-50 mM) influenced the DNA cleavage activity. Balsamin also demonstrated reducing power and a capacity to scavenge free radicals in a dose dependent manner. Furthermore, the protein exhibited antibacterial activity against Staphylococcus aureus, Salmonella enterica, Staphylococcus epidermidis and Escherichia coli, which suggests potential utility of balsamin as a nutraceutical.


Asunto(s)
Antibacterianos/farmacología , Desoxirribonucleasas/antagonistas & inhibidores , Momordica/química , Proteínas de Plantas/farmacología , Proteínas Inactivadoras de Ribosomas/farmacología , Antibacterianos/análisis , Antioxidantes/análisis , Antioxidantes/farmacología , Escherichia coli/efectos de los fármacos , Concentración de Iones de Hidrógeno , Magnesio/metabolismo , Extractos Vegetales/análisis , Extractos Vegetales/farmacología , Proteínas de Plantas/análisis , Proteínas Inactivadoras de Ribosomas/análisis , Salmonella enterica/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Staphylococcus epidermidis/efectos de los fármacos
8.
Asian Pac J Cancer Prev ; 17(4): 2277-84, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27221930

RESUMEN

Ribosome-inactivating protein (RIP) from Mirabilis jalapa L. leaves has cytotoxic effects on breast cancer cell lines but is less toxic towards normal cells. However, it can easily be degraded after administration so it needs to be formulated into nanoparticles to increase its resistance to enzymatic degradation. The objectives of this study were to develop a protein extract of M. jalapa L. leaves (RIP-MJ) incorporated into nanoparticles conjugated with Anti-EpCAM antibodies, and to determine its cytotoxicity and selectivity in the T47D breast cancer cell line. RIP-MJ was extracted from red-flowered M. jalapa L. leaves. Nanoparticles were formulated based on polyelectrolyte complexation using low viscosity chitosan and alginate, then chemically conjugated with anti-EpCAM antibody using EDAC based on carbodiimide reaction. RIP-MJ nanoparticles were characterised for the particle size, polydispersity index, zeta potential, particle morphology, and entrapment efficiency. The cytotoxicity of RIP-MJ nanoparticles against T47D and Vero cells was then determined with MTT assay. The optimal formula of RIP-MJ nanoparticles was obtained at the concentration of RIP-MJ, low viscosity chitosan and alginate respectively 0.05%, 1%, and 0.4% (m/v). RIP-MJ nanoparticles are hexagonal with high entrapment efficiency of 98.6%, average size of 130.7 nm, polydispersity index of 0.380 and zeta potential +26.33 mV. The IC50 values of both anti-EpCAM-conjugated and non-conjugated RIP-MJ nanoparticles for T47D cells (13.3 and 14.9 µg/mL) were lower than for Vero cells (27.8 and 33.6 µg/mL). The IC50 values of conjugated and non- conjugated RIP-MJ for both cells were much lower than IC50 values of non-formulated RIP-MJ (>500 µg/mL).


Asunto(s)
Anticuerpos Monoclonales/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/patología , Molécula de Adhesión Celular Epitelial/antagonistas & inhibidores , Mirabilis/química , Nanopartículas/química , Extractos Vegetales/farmacología , Proteínas Inactivadoras de Ribosomas/metabolismo , Alginatos/química , Apoptosis/efectos de los fármacos , Western Blotting , Neoplasias de la Mama/metabolismo , Proliferación Celular/efectos de los fármacos , Química Farmacéutica , Quitosano/química , Molécula de Adhesión Celular Epitelial/inmunología , Femenino , Citometría de Flujo , Ácido Glucurónico/química , Ácidos Hexurónicos/química , Humanos , Nanopartículas/administración & dosificación , Tamaño de la Partícula , Hojas de la Planta/química , Células Tumorales Cultivadas , Viscosidad
9.
J Food Drug Anal ; 24(4): 881-887, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-28911628

RESUMEN

Momordica charantia L., a vegetable crop with high nutritional value, has been used as an antimutagenic, antihelminthic, anticancer, antifertility, and antidiabetic agent in traditional folk medicine. In this study, the antifungal activity of M. charantia seed extract toward Fusarium solani L. was evaluated. Results showed that M. charantia seed extract effectively inhibited the mycelial growth of F. solani, with a 50% inhibitory rate (IC50) value of 108.934 µg/mL. Further analysis with optical microscopy and fluorescence microscopy revealed that the seed extract led to deformation of cells with irregular budding, loss of integrity of cell wall, as well as disruption of the fungal cell membrane. In addition, genomic DNA was also severely affected, as small DNA fragments shorter than 50 bp appeared on agarose gel. These findings implied that M. charantia seed extract containing α-momorcharin, a typical ribosome-inactivating protein, could be an effective agent in the control of fungal pathogens, and such natural products would represent a sustainable alternative to the use of synthetic fungicides.


Asunto(s)
Momordica charantia , Antifúngicos , Fusarium , Extractos Vegetales , Proteínas Inactivadoras de Ribosomas , Semillas
10.
Tumour Biol ; 37(6): 7703-12, 2016 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26692099

RESUMEN

Evaluation of the immunomodulatory activity of plant compounds is an interesting and growing area of research. Teucrium ramosissimum Desf. is a native and endemic medicinal plant from the South of Tunisia traditionally used for the treatment of many diseases. The anti-inflammatory activity of apigenin-7-glucoside, genkwanin, and naringenin isolated from T. ramosissimum were assayed. The phagocytic activities of macrophage and lymphocyte proliferation were investigated in the absence and presence of mitogens (lipopolysaccharide [LPS] or lectin). Depending on the concentrations, the compounds affect macrophage functions by modulating their lysosomal enzyme activity and nitric oxide (NO) release. The tested compounds enhance significantly splenocyte proliferation, either with or without mitogen stimulation. In studies to assess any potential effects of apigenin-7-glucoside, genkwanin, and naringenin on innate immunity, the results showed that these compounds significantly enhanced the killing activity of natural killer (NK) cells and cytotoxic activity of the T lymphocyte (CTL) isolated from splenocytes. These results suggest that T. ramosissimum compounds such as apigenin-7-glucoside, genkwanin, and naringenin may be potentially useful for modulating immune cell functions in physiological and pathological conditions.


Asunto(s)
Antioxidantes/farmacología , Inmunidad Innata/efectos de los fármacos , Factores Inmunológicos/farmacología , Extractos Vegetales/farmacología , Linfocitos T Citotóxicos/efectos de los fármacos , Teucrium/química , Animales , Antioxidantes/aislamiento & purificación , Apigenina/aislamiento & purificación , Apigenina/farmacología , Células Cultivadas/efectos de los fármacos , Endotoxinas/farmacología , Flavanonas/aislamiento & purificación , Flavanonas/farmacología , Flavonas/aislamiento & purificación , Flavonas/farmacología , Factores Inmunológicos/aislamiento & purificación , Células Asesinas Naturales/efectos de los fármacos , Activación de Linfocitos/efectos de los fármacos , Lisosomas/efectos de los fármacos , Lisosomas/enzimología , Macrófagos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Óxido Nítrico/metabolismo , Plantas Medicinales/química , Mitógenos de Phytolacca americana/farmacología , Proteínas Inactivadoras de Ribosomas/farmacología , Organismos Libres de Patógenos Específicos , Linfocitos T Citotóxicos/inmunología , Túnez
11.
Mol Plant Pathol ; 17(2): 261-71, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25976013

RESUMEN

The ribosome-inactivating protein BE27 from sugar beet (Beta vulgaris L.) leaves is an apoplastic protein induced by signalling compounds, such as hydrogen peroxide and salicylic acid, which has been reported to be involved in defence against viruses. Here, we report that, at a concentration much lower than that present in the apoplast, BE27 displays antifungal activity against the green mould Penicillium digitatum, a necrotrophic fungus that colonizes wounds and grows in the inter- and intracellular spaces of the tissues of several edible plants. BE27 is able to enter into the cytosol and kill fungal cells, thus arresting the growth of the fungus. The mechanism of action seems to involve ribosomal RNA (rRNA) N-glycosylase activity on the sarcin-ricin loop of the major rRNA which inactivates irreversibly the fungal ribosomes, thus inhibiting protein synthesis. We compared the C-terminus of the BE27 structure with antifungal plant defensins and hypothesize that a structural motif composed of an α-helix and a ß-hairpin, similar to the γ-core motif of defensins, might contribute to the specific interaction with the fungal plasma membranes, allowing the protein to enter into the cell.


Asunto(s)
Antifúngicos/farmacología , Beta vulgaris/metabolismo , Beta vulgaris/microbiología , Penicillium/fisiología , Proteínas de Plantas/metabolismo , Proteínas Inactivadoras de Ribosomas/metabolismo , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Beta vulgaris/efectos de los fármacos , Simulación por Computador , Modelos Moleculares , Datos de Secuencia Molecular , Penicillium/efectos de los fármacos , Penicillium/crecimiento & desarrollo , Proteínas de Plantas/química , Proteínas Inactivadoras de Ribosomas/química , Ribosomas/metabolismo
12.
Acta Crystallogr F Struct Biol Commun ; 71(Pt 9): 1152-5, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26323301

RESUMEN

The interaction of momordin, a type 1 ribosome-inactivating protein from Momordica charantia, with NADP(+) and NADPH has been investigated by X-ray diffraction analysis of complexes generated by co-crystallization and crystal soaking. It is known that the proteins of this family readily cleave the adenine-ribose bond of adenosine and related nucleotides in the crystal, leaving the product, adenine, bound to the enzyme active site. Surprisingly, the nicotinamide-ribose bond of oxidized NADP(+) is cleaved, leaving nicotinamide bound in the active site in the same position but in a slightly different orientation to that of the five-membered ring of adenine. No binding or cleavage of NADPH was observed at pH 7.4 in these experiments. These observations are in accord with current views of the enzyme mechanism and may contribute to ongoing searches for effective inhibitors.


Asunto(s)
Momordica charantia/química , NADP/química , NADP/metabolismo , NAD/metabolismo , Proteínas Inactivadoras de Ribosomas/química , Proteínas Inactivadoras de Ribosomas/metabolismo , Cristalización , Cristalografía por Rayos X , Extractos Vegetales/química , Estructura Secundaria de Proteína , Electricidad Estática
13.
Mol Cell Biochem ; 408(1-2): 73-87, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26152904

RESUMEN

In this study, we evaluated the effects of Korean mistletoe (Viscum album L. var. coloratum) coated with a biodegradable polymer (Eudragit(®)) wall on the growth of mouse melanoma in vivo. Oral administration of 4% (430 mg/kg/day) enteric-coated mistletoe resulted in a significant reduction in tumor volume on day 14 compared to the negative control group in B16F10 melanoma-inoculated BDF1 mice. When we measured the survival rate, enteric-coated mistletoe-received mice had a higher survival rate after day 12. Also, we investigated the mechanism involving the cancer cell growth inhibition when melanoma cells were treated with Korean mistletoe lectin (Viscum album L. var. coloratum agglutinin, VCA) and its extract in vitro. As a result, a significant G0/G1 arrest was observed in both B16BL6 and B16F10 melanoma cells with VCA or mistletoe extract. In addition, VCA or mistletoe extract induced an increase in both early and late apoptosis in cells. When we studied the molecular mechanism, our results showed that VCA and mistletoe extract can increase activated multiple caspases (caspase-1, 3, 4, 5, 6, 7, 8, and 9), dose-dependently. We also found out that VCA and mistletoe treatment causes a significant decrease in the expression of procaspase-3 and 8.


Asunto(s)
Antineoplásicos Fitogénicos/administración & dosificación , Melanoma Experimental/tratamiento farmacológico , Muérdago/metabolismo , Lectinas de Plantas/administración & dosificación , Proteínas Inactivadoras de Ribosomas/administración & dosificación , Neoplasias Cutáneas/tratamiento farmacológico , Administración Oral , Animales , Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/farmacología , Apoptosis , Caspasa 3/metabolismo , Caspasa 8/metabolismo , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Ensayos de Selección de Medicamentos Antitumorales , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Técnicas In Vitro , Melanoma Experimental/metabolismo , Ratones , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Lectinas de Plantas/química , Lectinas de Plantas/farmacología , Polímeros/química , Proteínas Inactivadoras de Ribosomas/química , Proteínas Inactivadoras de Ribosomas/farmacología , Neoplasias Cutáneas/metabolismo , Análisis de Supervivencia
14.
J Biosci ; 40(1): 125-35, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25740147

RESUMEN

Root extract of Boerhaavia diffusa L. induced systemic resistance in tobacco against Tobacco mosaic virus. A 30 kDa protein was isolated as the active component, called BDP-30 on the basis of the molecular weight and source plant. BDP-30, a glycoprotein, was found to be temperature and protease resistant. It was basic, possessing a pI greater than 9.0. In-gel proteolytic digestion of BDP-30 generated two peptides that possessed the amino acid sequence KLYDIPPLR and KVTLPYSGNYER by LC/MS/MS. Both peptides shared absolute sequence identity with trichosanthin, a ribosome-inactivating protein from Trichosanthes kirilowii, and a 78 percent and 100 percent homology respectively with an RIP from Bryonia dioica, bryodin. Further, effort was made to look at the fate of TMV in induced resistant Nicotiana tabacum cv. Xanthi, a systemic host of the virus, at specified days after inoculation in control and treated plants. TMV coat protein (CP) was detected by immunoblot 7 days post inoculation up to 21 days in the control set, but not in treated resistant plants. TMV RNA was detected by RT-PCR using TMV-CP specific primers. Resistant tobacco did not show presence of TMV RNA up to 21 days of inoculation. This suggests that BDP-30 may be suppressing TMV replication.


Asunto(s)
Glicoproteínas/genética , Nicotiana/virología , Nyctaginaceae/metabolismo , Proteínas de Plantas/genética , Proteínas Inactivadoras de Ribosomas/genética , Virus del Mosaico del Tabaco/efectos de los fármacos , Proteínas de la Cápside/aislamiento & purificación , Resistencia a la Enfermedad/efectos de los fármacos , Glicoproteínas/metabolismo , Inmunidad Innata , Enfermedades de las Plantas/prevención & control , Enfermedades de las Plantas/virología , Extractos Vegetales/genética , Extractos Vegetales/metabolismo , Proteínas de Plantas/metabolismo , Raíces de Plantas/metabolismo , Proteínas Inactivadoras de Ribosomas/metabolismo , Ribosomas , Replicación Viral/efectos de los fármacos
15.
Molecules ; 20(2): 2364-87, 2015 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-25647575

RESUMEN

Sambucus (Adoxaceae) species have been used for both food and medicine purposes. Among these, Sambucus nigra L. (black elder), Sambucus ebulus L. (dwarf elder), and Sambucus sieboldiana L. are the most relevant species studied. Their use has been somewhat restricted due to the presence of bioactive proteins or/and low molecular weight compounds whose ingestion could trigger deleterious effects. Over the last few years, the chemical and pharmacological characteristics of Sambucus species have been investigated. Among the proteins present in Sambucus species both type 1, and type 2 ribosome-inactivating proteins (RIPs), and hololectins have been reported. The biological role played by these proteins remains unknown, although they are conjectured to be involved in defending plants against insect predators and viruses. These proteins might have an important impact on the nutritional characteristics and food safety of elderberries. Type 2 RIPs are able to interact with gut cells of insects and mammals triggering a number of specific and mostly unknown cell signals in the gut mucosa that could significantly affect animal physiology. In this paper, we describe all known RIPs that have been isolated to date from Sambucus species, and comment on their antiviral and entomotoxic effects, as well as their potential uses.


Asunto(s)
Frutas/química , Extractos Vegetales/farmacología , Proteínas Inactivadoras de Ribosomas/farmacología , Sambucus/química , Animales , Humanos , Terapia Molecular Dirigida , Extractos Vegetales/aislamiento & purificación , Proteínas Inactivadoras de Ribosomas/aislamiento & purificación , Proteínas Inactivadoras de Ribosomas/fisiología
16.
Toxins (Basel) ; 7(1): 156-69, 2015 Jan 19.
Artículo en Inglés | MEDLINE | ID: mdl-25606813

RESUMEN

Ribosome inactivating proteins (RIPs) inhibit protein synthesis by depurinating the large ribosomal RNA and some are found to possess anti-human immunodeficiency virus (HIV) activity. Maize ribosome inactivating protein (RIP) has an internal inactivation loop which is proteolytically removed for full catalytic activity. Here, we showed that the recombinant active maize RIP protected chimeric simian-human immunodeficiency virus (SHIV) 89.6-infected macaque peripheral blood mononuclear cells from lysis ex vivo and transiently reduced plasma viral load in SHIV89.6-infected rhesus macaque model. No evidence of immune dysregulation and other obvious side-effects was found in the treated macaques. Our work demonstrates the potential development of maize RIP as an anti-HIV agent without impeding systemic immune functions.


Asunto(s)
Antirretrovirales/uso terapéutico , Proteínas Inactivadoras de Ribosomas/uso terapéutico , Síndrome de Inmunodeficiencia Adquirida del Simio/tratamiento farmacológico , Virus de la Inmunodeficiencia de los Simios , Carga Viral/efectos de los fármacos , Zea mays , Animales , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/virología , Macaca mulatta , Masculino , Proteínas Recombinantes/uso terapéutico , Síndrome de Inmunodeficiencia Adquirida del Simio/sangre , Síndrome de Inmunodeficiencia Adquirida del Simio/virología
17.
Fitoterapia ; 100: 139-49, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25447153

RESUMEN

Alpha-momorcharin (α-MMC), a ribosome inactivating protein (RIP) extracted from the seeds of Momordica charantia, exerts anti-tumor, antiviral, and anti-fungal activities. However, α-MMC has an obvious toxicity that limits its clinical application. We examined the effect of α-MMC on the inhibition of human breast cancer and assessed its general toxicity to find the therapeutic window in vivo for its potential clinical use. It was purified using column chromatography, and then injected into the xenograft nude mouse model induced by MDA-MB-231 and MCF-7. The anti-tumor efficacy was evaluated with T/C%. Next, the α-MMC was injected at a series of doses to Balb/C mice to assess its general toxicity. The MTT assay, the apoptosis test, and the cell cycle inhibition of α-MMC in human breast cancer cells were performed. In the xenografted tumors induced by MDA-MB-231 and MCF-7, α-MMC exerted an obvious inhibition effects on tumor growth at the dosage of 1.2mg/kg and 0.8 mg/kg. For in vivo toxicity experiments of α-MMC in Balb/C mice, the minimal toxic dose of α-MMC was 1.2mg/kg. Alpha-MMC induced apoptosis by increasing caspase3 activities, and the cell cycle was arrested at the G0/G1 or G2/M phases. The measurements of IC50 were 15.07 µg/mL, 33.66 µg/mL, 42.94 µg/mL for MDA-MB-231, MCF-7 and MDA-MB-453 respectively. Alpha-MMC exhibits anti-tumor effects in human breast cancer in vivo and in vitro. It inhibits breast cancer cells through the inhibition of tumor growth and induction of cell apoptosis. However, due to its obvious toxicity, α-MMC has a relatively narrow therapeutic window in vivo.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Neoplasias de la Mama/patología , Proteínas Inactivadoras de Ribosomas/farmacología , Animales , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Femenino , Humanos , Ratones Endogámicos BALB C , Ratones Desnudos , Momordica charantia/química , Proteínas Inactivadoras de Ribosomas/toxicidad , Semillas/química , Pruebas de Toxicidad , Ensayos Antitumor por Modelo de Xenoinjerto
18.
Mol Cell Biochem ; 388(1-2): 233-40, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24297707

RESUMEN

A multitude of plants have been used extensively for the treatment of cancers throughout the world. The protein, α, ß momorcharin has been extracted from the plant Momordica charantia (MC), and it possesses anti-cancer and anti-HIV properties similar to the crude water and methanol soluble extract of the plant. This study investigated the anti-cancer effects and the cellular mechanisms of action of α, ß momocharin (200-800 µM) on 1321N1, Gos-3, U87-MG, Sk Mel, Corl-23 and Weri Rb-1 cancer cell lines compared to normal healthy L6 muscle cell line measuring cell viability using MTT assay kit, Caspase-3 and 9 activities, cytochrome c release and intracellular free calcium concentrations [Ca(2+)]i. The results show that α, ß momorcharin can evoke significant dose-dependent (P < 0.05; Student's t test) decreases in the viability (increases in cell death) of 1321N1, Gos-3, U87-MG, Sk Mel, Corl-23 and Weri Rb-1 cancer cell lines compared to healthy L6 muscle cell line and untreated glioma cells. α, ß momorcharin (800 µM) also evoked significant (P < 0.05) increases in caspase-3 and 9 activities and cytochrome c release. Similarly, α, ß momorcharin elicited significant (P < 0.05) time-dependent elevation in [Ca(2+)]i in all five glioma cell lines compared to untreated cells. Together, the results have demonstrated that α, ß momorcharin can exert its anti-cancer effect on different cancer cell lines by intracellular processes involving an insult to the mitochondria resulting in cellular calcium over loading, apoptosis, cytochrome release and subsequently, cell death.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Glioma/tratamiento farmacológico , Proteínas Inactivadoras de Ribosomas/farmacología , Apoptosis/efectos de los fármacos , Calcio/metabolismo , Caspasa 3/biosíntesis , Caspasa 9/biosíntesis , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Citocromos c/metabolismo , Humanos , Momordica charantia/metabolismo , Extractos Vegetales/farmacología
19.
Int J Mol Sci ; 14(8): 15532-45, 2013 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-23892598

RESUMEN

Ribosome-inactivating proteins (RIPs), enzymes that are widely distributed in the plant kingdom, inhibit protein synthesis by depurinating rRNA and many other polynucleotidic substrates. Although RIPs show antiviral, antifungal, and insecticidal activities, their biological and physiological roles are not completely understood. Additionally, it has been described that RIP expression is augmented under stressful conditions. In this study, we evaluated protein synthesis inhibition activity in partially purified basic proteins (hereafter referred to as RIP activity) from tissue extracts of Fragaria × ananassa (strawberry) cultivars with low (Dora) and high (Record) tolerance to root pathogens and fructification stress. Association between the presence of RIP activity and the crop management (organic or integrated soil), growth stage (quiescence, flowering, and fructification), and exogenous stress (drought) were investigated. RIP activity was found in every tissue tested (roots, rhizomes, leaves, buds, flowers, and fruits) and under each tested condition. However, significant differences in RIP distribution were observed depending on the soil and growth stage, and an increase in RIP activity was found in the leaves of drought-stressed plants. These results suggest that RIP expression and activity could represent a response mechanism against biotic and abiotic stresses and could be a useful tool in selecting stress-resistant strawberry genotypes.


Asunto(s)
Fragaria/enzimología , Fragaria/metabolismo , Extractos Vegetales/metabolismo , Proteínas Inactivadoras de Ribosomas/metabolismo , Animales , Estadios del Ciclo de Vida , Biosíntesis de Proteínas , ARN Ribosómico/antagonistas & inhibidores , ARN Ribosómico/metabolismo , Estrés Fisiológico
20.
Toxicon ; 67: 12-6, 2013 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-23462379

RESUMEN

Ribosome-inactivating proteins (RIPs) either single-chain (type 1) or two-chain (type 2) are frequent in plants, often in multiple forms. They are RNA N-glycosidases, have antiviral, antifungal and insecticidal activity. Their expression in plants is increased under stressful conditions. They are investigated for practical applications in medicine and in agriculture. In medicine, RIPs have been linked to, or fused with, appropriate antibodies or other carriers to form "immunotoxins" or other conjugates specifically toxic to the cells target of the carrier, with the aim of eliminating malignant or other undesired cells. In agriculture, it has been observed that an enhanced expression of RIPs confers to plants an increased resistance to viruses, fungi, insects, and also to drought and salinity.


Asunto(s)
Proteínas Inactivadoras de Ribosomas/toxicidad , Proteínas Inactivadoras de Ribosomas/uso terapéutico , Proteínas Algáceas/uso terapéutico , Proteínas Algáceas/toxicidad , Animales , Antifúngicos , Antivirales , Proteínas Bacterianas/uso terapéutico , Proteínas Bacterianas/toxicidad , Proteínas Fúngicas/uso terapéutico , Proteínas Fúngicas/toxicidad , Humanos , Inmunotoxinas/uso terapéutico , Inmunotoxinas/toxicidad , Insecticidas , Control Biológico de Vectores , Proteínas de Plantas/uso terapéutico , Proteínas de Plantas/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA